当前位置: 首页 > 期刊 > 《新医学》 > 20182
编号:13600900
爆发性脉络膜上腔出血研究进展(4)
http://www.100md.com 2018年2月1日 《新医学》 20182
     [16]Feretis E, Mourtzoukos S, Mangouritsas G, Kabanarou SA, Inoba K, Xirou T Secondary management and outcome of massive suprachoroidal hemorrhage Eur J Ophthatmal, 2006,16(6):835840

    [17]Murata T, Kikushima W, Imai A, Toriyama Y, Tokimitsu M, Kurokawa T Tissuetype plasminogen activatorassisted drainage of suprachoroidal hemorrhage showing a kissing configuration Jpn J Ophthalmol, 2011, 55(4):431432

    [18]Valldeperas X, Elizalde J, Romano M, Wong DHeavy silicone oil(densiron) and supine position in the management of massive suprachoroidal hemorrhage : use of heavy silicone for suprachoroidal hemorrhage Retin Cases Brief Rep,2012,6(1):8081

    [19]Kamei M, Estafanous M, Lewis H Tissue plasminogen activator in the treatment of vitreoretinal diseases Semin Ophthalmol, 2000,15(1):4450

    [20]Kunjukunju N, Gonzales CR, Rodden WS Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhageClin Ophthalmol,2011,5:155157

    (收稿日期:20170906)

    (本文編辑:杨江瑜), http://www.100md.com(孙方格 王司仪 牛灵芝 刘早霞)
上一页1 2 3 4